Nuclear AXIN2 represses MYC gene expression.

Area of Science:

• Molecular Biology
• Cancer Biology
• Cell Signaling

Background:

• The canonical Wnt signaling pathway, mediated by β-catenin, is crucial for cell development and implicated in cancer.
• AXIN2, a component of the β-catenin destruction complex, typically functions in a negative feedback loop.
• The nuclear role of AXIN2 in Wnt/β-catenin signaling remains largely uncharacterized.

Purpose of the Study:

• To investigate the nuclear function of AXIN2 in the Wnt/β-catenin signaling pathway.
• To determine the impact of nuclear AXIN2 on gene expression, particularly MYC.
• To elucidate the mechanism by which nuclear AXIN2 regulates Wnt signaling.

Main Methods:

• Immunofluorescence and Western blotting to confirm AXIN2 nuclear localization in colorectal cancer tissues and cell lines.
• Luciferase reporter assays to assess the effect of AXIN2 on Wnt/β-catenin-responsive gene expression.
• Chromatin immunoprecipitation (ChIP) assays to identify co-occupancy of AXIN2, β-catenin, and TCF at target gene promoters.
• Analysis of chromatin structure modifications at the MYC promoter.

Main Results:

• AXIN2 was confirmed to localize in the nuclei of epithelial cells in normal and tumor tissues, as well as in colorectal cancer cell lines.
• Nuclear AXIN2 was found to repress Wnt/β-catenin-responsive gene expression, including MYC.
• AXIN2 forms complexes with β-catenin and TCF, co-occupying the MYC promoter region.
• Constitutive nuclear localization of AXIN2 alters chromatin structure and directly represses MYC gene expression.

Conclusions:

• Nuclear AXIN2 acts as a transcriptional repressor, specifically targeting MYC expression.
• AXIN2 functions as a rheostat, modulating MYC expression in response to Wnt/β-catenin signaling.
• These findings uncover a novel regulatory mechanism for MYC in colorectal cancer and provide potential therapeutic targets.